glp 1 retinopathy The TGA has issued a warning on the potential for high-profile GLP-1 RA medications to cause a rare but severe eye condition. #newsGP https://www1.racgp.org.au/newsgp/clinical/tga-issues-glp-1 -ra-class-wide-safety-update Ocular Effects of GLP-1 Receptor

Bickerton 6 , J

Many of my patients naturally gravitate toward lighter, more nutritious foods because heavy meals become less appealing

(Source: Pigment International, 2017) A standard glutathione IV drip typically contains: Glutathione (600mg to 2400mg, depending on the formulation and clinic) Vitamin C (often included because it enhances glutathione absorption and has its own brightening and collagen-supporting properties) The IV delivery method is significant

Serious risks (rare): Pancreatitis, gallbladder issues, or thyroid tumors in people with certain genetic conditions

Tirzepatide went further: in the SURMOUNT-1 trial led by Ania Jastreboff in 2022, the highest dose produced a mean loss of around 21% over 72 weeks figures that, at the high end, overlap with what bariatric surgery typically achieves